Browsing by Subject "Potassium Channels, Inwardly Rectifying"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Regulation of Endocytosis of ROMK Channel by WNK Kinase Family(2009-09-04) Wang, Hao-Ran; Huang, Chou-LongWNK kinases are members of a novel family of serine/threonine kinases with atypical placement of the catalytic lysine. Mutations in WNK1 and WNK4 cause pseudohypoaldosteronism type 2 (PHA2), an autosomal-dominant disease characterized by hypertension and hyperkalemia. Renal outer medullary potassium channel (ROMK) is responsible for constitutive K+ secretion in the kidney. WNK1 and WNK4 stimulate the clathrin-mediated endocytosis of ROMK, which contributes to the pathogenesis of hyperkalemia in PHAII patients. Intersectin (ITSN) is a multimodular endocytic scaffold protein. The proline-rich domains of WNK1 and WNK4 bind with the Src-homology domain (SH3) of intersectin, and this interaction is important for the stimulation of endocytosis of ROMK by WNKs. Intersectin will further activate the GTPase activity of dynamin and the actin polymerization of N-WASP, and thus promote endocytosis of ROMK channel. WNK1 inhibition of ROMK is further regulated by the kinase domain conformation, which is critical for WNK1 to recruit intersectin. A shorter renal alternatively spliced form of WNK1 that lacks the kinase domain, known as kidney specific WNK1 (KSWNK1),interacts with WNK1 kinase domain and antagonizes WNK1 inhibition of ROMK. The 4a domain and the auto-inhibitory domain in KS-WNK1 are responsible for the antagonization. The antagonism of WNK1 by 4a domain of KS-WNK1 can be abolished by 2-BP (a palmitoylation inhibitor) and hydrogen peroxide (generated during K+ deficiency). These results provide a molecular mechanism for the regulation of endocytosis of ROMK by WNK kinase family.Item Understanding Potassium Homeostasis Using Human and Mouse Genetic Models(2013-01-17) Cheng, Chih-Jen; Huang, Chou-Long, M.D., PH.D.Potassium homeostasis is one of the most sophisticated processes involving multiple organs in mammals. Many physiological functions, such as excitability of muscles and neurons, rely on stable extracellular potassium concentration. To maintain potassium homeostasis, endogenous factors including hormones and peptides regulate the activity of potassium transporters in many organs, especially skeletal muscles and kidneys, in response to different conditions. To study the perplexed regulations of potassium transporters, I choose two genetic models of human potassium disorders, hypokalemic periodic paralysis (hypoPP) and pseudohypoaldosteronism type II (PHA2). Patients with hypoPP are characterized with ictal hypokalemia and muscle paralysis. HypoPP can be divided into familial and non-familial forms. Recent studies have revealed the pathogenesis of familial hypoPP. However, the pathogenesis of non-familial hypoPP, mainly composed of thyrotoxic or sporadic periodic paralysis (TPP/SPP), is mostly unknown. A novel muscle-specific inward-rectifying potassium (Kir) channel, Kir2.6, has been recently suggested to play a role in TPP. Here, I focus on studying the role of Kir channels in non-familial hypoPP and propose the disease mechanisms to explain hypokalemia and muscle paralysis. PHA2 is a genetic disorder caused by mutations on with-no-lysine kinase 1 or 4 (WNK1/4) and featured with hyperkalemia and hypertension. Studies in PHA2 have revealed that WNK kinases regulate renal sodium transporters and potassium channels. WNK1 enhances the endocytosis of renal outer medullary potassium (ROMK) channel through an intersectin-dependent mechanism, but the upstream regulator is still unknown. Here, I clarified that the phosphoinositol-3-kinase-induced activation of Akt1/SGK can phosphorylate threonin 58 of WNK1 and thus inhibits ROMK current in cultured cells. In addition to full-length WNK1, the kinase-deficient WNK1 isoform, kidney-specific WNK1 (KS-WNK1), also participates in the regulation of renal sodium and potassium handling. Previous studies have shown that high potassium intake enhances KS-WNK1 expression and suppresses renal sodium reabsorption in thick ascending limb (TAL). However, the localization and function of KS-WNK1 in TAL are still debatable. Here, I used KS-WNK1 genetic mouse models to demonstrate that KS-WNK1 is present and function to inhibit sodium reabsorption in cortical TAL. These results contribute to the understanding of potassium homeostasis in skeletal muscle and kidney.